New EU Restrictions On Biogen’s MS Drug Zinbryta Are ‘Damaging’, Analyst Warns

 
• By Neena Brizmohun
  
Multiple Sclerosis
The EMA is placing further restrictions on the use of Biogen's MS drug
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Drug Safety

More from Pink Sheet